Immunoglobulin G/immunoglobulin M autoantibody ratios in incomplete systemic lupus erythematosus
Open Access
- 20 March 2024
- journal article
- research article
- Published by Taylor & Francis in Scandinavian Journal of Rheumatology
- Vol. 53 (3) , 207-216
Abstract
ObjectiveImmunoglobulin G (IgG) autoantibodies in systemic lupus erythematosus (SLE) are considered pathogenic, whereas immunoglobulin M (IgM) autoantibodies may have protective effects. The aim of this study was to identify whether IgG/IgM autoantibody ratios differ between patients with incomplete systemic lupus erythematosus (iSLE), patients with SLE, and healthy controls (HCs), and whether IgG/IgM autoantibody ratios relate to progression from iSLE to SLE.MethodThis prospective cohort study included 34 iSLE patients, 41 SLE patients, and 11 HCs. IgG and IgM anti-dsDNA, anti-Ro52, and anti-Ro60 were measured by fluoro-enzyme immunoassay in serum samples obtained at baseline in all groups and in follow-up samples of up to 5 years for iSLE patients. Correlations between IgG/IgM autoantibody ratios, interferon signature, and clinical parameters were also assessed.ResultsAt baseline, IgG anti-dsDNA, anti-Ro52, anti-Ro60, and IgM anti-dsDNA were elevated in iSLE and SLE patients. IgG/IgM anti-dsDNA and anti-Ro52 ratios were similar between groups, while IgG/IgM anti-Ro60 ratios were significantly elevated in iSLE and SLE patients compared to HCs. IgG/IgM autoantibody ratios were not correlated with interferon signature or clinical parameters. IgG/IgM ratios at baseline were similar and remained relatively stable during a median follow-up of 18 months in non-progressors and six iSLE patients who progressed to SLE.ConclusionIgG anti-dsDNA, anti-Ro52, anti-Ro60, and IgM anti-dsDNA were elevated in iSLE and SLE patients, which was not apparent from the respective IgG/IgM ratios only. IgG/IgM autoantibody ratios remained relatively stable over up to 5 years in iSLE non-progressors and six patients who progressed to SLE.Keywords
Funding Information
- ReumaNederland (15-1-401)
- Thermo Fisher Scientific
This publication has 32 references indexed in Scilit:
- From incomplete to complete systemic lupus erythematosus; A review of the predictive serological immune markersSeminars in Arthritis and Rheumatism, 2021
- The REDCap consortium: Building an international community of software platform partnersJournal of Biomedical Informatics, 2019
- Incomplete Systemic Lupus Erythematosus: What Remains After Application of American College of Rheumatology and Systemic Lupus International Collaborating Clinics criteria?Arthritis Care & Research, 2019
- Depressed serum IgM levels in SLE are restricted to defined subgroupsClinical Immunology, 2017
- IgG and IgM Autoantibody Differences in Discoid and Systemic Lupus PatientsJournal of Investigative Dermatology, 2012
- Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosusArthritis & Rheumatism, 2012
- The importance of natural IgM: scavenger, protector and regulatorNature Reviews Immunology, 2010
- IgM Antibodies Against dsDNA in SLEClinical Reviews in Allergy & Immunology, 2007
- Coordinate overexpression of interferon‐α–induced genes in systemic lupus erythematosusArthritis & Rheumatism, 2004
- IgM anti-dsDNA antibodies in systemic lupus erythematosus: negative association with nephritisRheumatology International, 1998